Table 7.

 Relative risks (expressed as odds ratios) for the Toll-like receptor 4 (TLR4) and NOD2 genotypes

	Wild-type	Heterozygous	Homozygous mutant
NOD2 mutations
CD	251	163	34
Controls	109	28	3
OR (95% CI)	1	2.528 (1.562–4.11)	4.199 (1.41–20.513)
TLR4 Asp299Gly
CD	353	89	5
Controls	126	12	1
OR (95% CI)	1	2.652 (1.356–5.274)	1.780 (0.201–40.619)

CD, Crohn’s disease; OR, odds ratio; 95% CI, 95% confidence interval.

For TLR4 Asp299Gly, one CD patient and one control could not be genotyped.